# VItamin K Inhibition and NeurocoGnition (VIKING)

> **NCT03276377** · — · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 100 (estimated)

## Conditions studied

- Neurocognitive Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03276377
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03276377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03276377, "VItamin K Inhibition and NeurocoGnition (VIKING)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03276377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*